Dysregulation of TGFβ signalling is identified in mouse and human cell models of Huntington's disease. Characterisation of this dysregulation in downstream SMAD transcription factors is presented. SMAD3 binds to the HTT promotor and can regulate HTT expression in the absence of a CAG expansion.